Consequently, bacterial components and detrimental agents are released within the gut–liver axis, triggering an immune response that initiates inflammation and prompts an elevated secretion of IL-6, fostering the progression of HCC [126]. The gene discussed is IL6; the disease is hepatocellular carcinoma.